Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of the Hepatitis B Vaccination Post Hypothermia for Hypoxic Ischemic Encephalopathy

NCT05787899 is registered in ClinicalTrials.gov with Medical University of South Carolina as lead sponsor.

NCT NCT05787899
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05787899 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of the Hepatitis B Vaccination Post Hypothermia for Hypoxic Ischemic Encephalopathy
Lead sponsor
Medical University of South Carolina
Phase
Observational
Overall status
Completed
Start date
May 18, 2023
Completion date
October 1, 2024
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b vaccination, hypothermia, newborn, hypoxic-ischemic encephalopathy